Latest Pseudomonas Stories
Bacteria use various appendages to move across surfaces prior to forming multicellular bacterial biofilms.
MONMOUTH JUNCTION, N.J., June 10, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced positive data through six treatment cycles (72 weeks total duration) of its Phase 2 clinical trial program for ARIKACEÂ® (liposomal amikacin for inhalation) in cystic fibrosis (CF) patients with Pseudomonas lung infections.
As it turns out, humans aren't the only organisms that turn to caffeine for a pick-me-up.
A new bacterium that uses caffeine for food has been discovered by a doctoral student at the University of Iowa.
VIENNA, April 1, 2011 /PRNewswire/ -- Today Intercell AG (VSE: ICLL) announced that it has agreed with Novartis to advance Intercell's investigational Pseudomonas aeruginosa vaccine into a confirmatory clinical efficacy trial in ventilated ICU (Intensive Care Unit) patients.
Encapsulating antibiotics inside nanofibers, like a mummy inside a sarcophagus, gives them the amazing ability to destroy drug-resistant bacteria so completely that scientists described the remains as mere "ghosts".
Recent research aboard the space shuttle is giving scientists a better understanding of how infectious disease occurs in space and could someday improve astronaut health and provide novel treatments for people on Earth.
A team of scientists from the University of Oxford, U.K. have taken lessons from Adam Smith and Charles Darwin to devise a new strategy that could one day slow, possibly even prevent, the spread of drug-resistant bacteria. In a new research report published in the March 2011 issue of GENETICS (http://www.genetics.org), the scientists show that bacterial gene mutations that lead to drug resistance come at a biological cost not borne by nonresistant strains.
Agile Sciencesâ€™ pharmaceutical compounds to be assessed for efficacy against bacterial isolates from cystic fibrosis patients. Raleigh, NC (PRWEB) March 11, 2011 Agile Sciences has been awarded a $75,000 grant from the Cystic Fibrosis Foundation which will facilitate testing of the companyâ€™s lead pharmaceutical compounds toward bacterial isolates from cystic fibrosis patients.
Plants are able to protect themselves from most bacteria, but some bacteria are able to breach their defences.
Pseudomonas aeruginosa is a common bacterium that can cause disease in animals and humans. It can be found in soil, water, skin flora, and most man-made environments throughout the world. It thrives in normal or hypoxic atmospheres; due to this it has colonized many natural and artificial environments. It can infect animals with damaged tissue or people with reduced immunity. Symptoms are generalized inflammation and sepsis. It can be fatal if colonization occurs in critical body organs,...
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.